London Stock Exchange Group shares steady after 7% slide as AI concerns return

London Stock Exchange Group shares steady after 7% slide as AI concerns return

June 19, 2026

London, June 19, 2026, 11:17 BST

  • LSEG traded near 8,314 pence on Friday morning, down about 0.3% after Thursday’s 7% fall.
  • Rothschild & Co Redburn cut the stock to neutral and lowered its target to £104 from £120, citing AI disruption risks.
  • The July 30 interim results will test whether adoption of LSEG’s AI-ready data services is converting into paid growth.

London Stock Exchange Group shares steadied on Friday after a broker downgrade triggered their steepest decline in months. The stock was about 0.3% lower at roughly 8,314 pence by 10:59 BST, following Thursday’s 7% drop, when LSEG was the FTSE 100’s biggest faller.

The scale of Thursday’s move reopened a question that LSEG had begun to contain: whether artificial intelligence will expand distribution of its licensed financial data or weaken the value of terminal-based workflows. The market reaction suggests investors still attach a heavy discount to that uncertainty.

Rothschild & Co Redburn cut LSEG to “neutral” from “buy” and reduced its price target — a broker’s estimate of fair value — to £104 from £120. The firm said real-time feeds, indices and clearing infrastructure remained relatively protected, but terminals, workflow products and much non-real-time data faced pressure from cheaper, modular AI access. It estimated that about 30% of group EBITDA, a measure of operating profit before interest, tax, depreciation and amortisation, was exposed to downside risk in its base case. Investing.com India

LSEG’s latest operating update points the other way. First-quarter income excluding costs passed through to clients rose 9.8% after stripping out currency and portfolio effects, while more than 150 customers had connected or were onboarding to its Model Context Protocol server, a gateway that lets authorised AI systems retrieve licensed data. “Our focus through 2026 will be on roll-out and adoption of these services,” Chief Executive David Schwimmer said. The company expects annual growth in the upper half of its 6.5%-7.5% range and remains on track for a £3 billion share-repurchase programme. LSEG

Analysts remain divided over whether usage will become meaningful revenue. UBS analyst Michael Werner said: “There is still a ‘show me’ story for AI. It’s one thing to have usage, it’s another to start charging people.” Bank of America has credited LSEG with presenting itself more clearly as part of the AI ecosystem, while Deutsche Bank has argued the stock looks inexpensive against data peers. Reuters reported last week that LSEG traded below the expected-earnings valuations of Moody’s and MSCI, though above FactSet. Reuters

That valuation gap is both the opportunity and the trap. LSEG owns hard-to-replicate index, real-time market-data and clearing assets. Yet Workspace and slower-moving datasets still resemble software products whose prices could be challenged. Thursday’s selloff showed that the protected businesses alone have not settled the argument.

But the downside case is plain. If AI agents allow banks and asset managers to bypass LSEG screens or purchase smaller data packages, pricing and margins could weaken. A planned UK “consolidated tape” — one feed combining trades from several venues — could also make some exchange data cheaper or more widely available. London Stock Exchange CEO Julia Hoggett said this month she may appeal to the government if the Financial Conduct Authority proceeds with its proposed design. Reuters

Broader markets were calmer on Friday. The FTSE 100 was down about 0.1% at 10:47 BST, while the pan-European STOXX 600 gained 0.2% as energy and healthcare shares advanced. LSEG’s modest decline therefore looked more like consolidation after Thursday’s selloff than another sharp leg lower.

The next scheduled test comes with LSEG’s interim results on July 30. Investors will look for evidence of paid AI adoption, continued growth in Workflows and Data & Feeds, margin progress and the pace of share repurchases.

Until then, LSEG is likely to trade as two businesses at once: scarce financial-market infrastructure and a data platform exposed to technology-led price pressure. Which side investors emphasise will continue to drive the stock.

Mateusz Ługowik

Mateusz Ługowik is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Gdańsk, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Stock Market Today

  • BioPharma Credit PLC Declares Interim Dividend for Q2 2026
    June 19, 2026, 6:24 AM EDT. BioPharma Credit PLC announced an interim dividend of 1.75 cents per share for the quarter ending June 30, 2026. The dividend, payable on July 31, 2026, targets a 7-cent annual base payout through four quarterly payments. The company, a specialist investor in life sciences debt, designates the full dividend as an interest distribution for UK tax purposes, reducing its corporation tax liability. Shares traded at 95.40 cents on June 18, 2026. Shareholders may elect to receive dividends in sterling (GBP) by July 3, 2026. BioPharma Credit focuses on generating long-term returns through debt assets secured by royalties from life sciences product sales, maintaining its investment trust status and sustainable income distributions.